Literature DB >> 23545286

The Drosophila clotting system and its messages for mammals.

Ulrich Theopold1, Robert Krautz, Mitchell S Dushay.   

Abstract

Drosophila has been increasingly used as a model to study hemolymph clotting. Proteomics and bioinformatics identified candidate clotting-factors, several of which were tested using genetics. Mutants and lines with reduced expression of clotting-factors show subtle effects after wounding, indicating that sealing wounds may rely on redundant mechanisms. More striking effects are observed after infection, in particular when a natural infection model involving entomopathogenic nematodes is used. When translated into mammalian models these results reveal that mammalian blood clots serve a similar immune function, thus providing a new example of the usefulness of studying invertebrate models.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  APMAP; Hml; Ig; Innate immunity; Insect immunity; Phenoloxidase; Transglutaminase; adipocyte membrane associated protein; hemolectin; immunoglobulin

Mesh:

Substances:

Year:  2013        PMID: 23545286     DOI: 10.1016/j.dci.2013.03.014

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  28 in total

Review 1.  Innate and intrinsic antiviral immunity in Drosophila.

Authors:  Assel Mussabekova; Laurent Daeffler; Jean-Luc Imler
Journal:  Cell Mol Life Sci       Date:  2017-01-19       Impact factor: 9.261

2.  Drosophila TG-A transglutaminase is secreted via an unconventional Golgi-independent mechanism involving exosomes and two types of fatty acylations.

Authors:  Toshio Shibata; Jinki Hadano; Daichi Kawasaki; Xiaoqing Dong; Shun-Ichiro Kawabata
Journal:  J Biol Chem       Date:  2017-05-05       Impact factor: 5.157

3.  Nitric oxide levels regulate the immune response of Drosophila melanogaster reference laboratory strains to bacterial infections.

Authors:  Ioannis Eleftherianos; Kareen More; Stephanie Spivack; Ethan Paulin; Arman Khojandi; Sajala Shukla
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

4.  Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.

Authors:  Yunting Lin; Hua He; Yingying Luo; Ting Zhu; Ranhui Duan
Journal:  Neurotox Res       Date:  2014-12-11       Impact factor: 3.911

5.  Drosophila as a model for the two myeloid blood cell systems in vertebrates.

Authors:  Katrina S Gold; Katja Brückner
Journal:  Exp Hematol       Date:  2014-06-17       Impact factor: 3.084

Review 6.  Tumour-host interactions through the lens of Drosophila.

Authors:  David Bilder; Katy Ong; Tsai-Ching Hsi; Kavya Adiga; Jung Kim
Journal:  Nat Rev Cancer       Date:  2021-08-13       Impact factor: 60.716

7.  Anti-Fibrotic Activity of an Antimicrobial Peptide in a Drosophila Model.

Authors:  Dilan Khalili; Christina Kalcher; Stefan Baumgartner; Ulrich Theopold
Journal:  J Innate Immun       Date:  2021-05-17       Impact factor: 7.349

8.  A Drosophila immune response against Ras-induced overgrowth.

Authors:  Thomas Hauling; Robert Krautz; Robert Markus; Anne Volkenhoff; Lucie Kucerova; Ulrich Theopold
Journal:  Biol Open       Date:  2014-04-15       Impact factor: 2.422

9.  Comparative genomic study of arachnid immune systems indicates loss of beta-1,3-glucanase-related proteins and the immune deficiency pathway.

Authors:  J Bechsgaard; B Vanthournout; P Funch; S Vestbo; R A Gibbs; S Richards; K W Sanggaard; J J Enghild; T Bilde
Journal:  J Evol Biol       Date:  2015-11-22       Impact factor: 2.411

10.  Toll mediated infection response is altered by gravity and spaceflight in Drosophila.

Authors:  Katherine Taylor; Kurt Kleinhesselink; Michael D George; Rachel Morgan; Tangi Smallwood; Ann S Hammonds; Patrick M Fuller; Perot Saelao; Jeff Alley; Allen G Gibbs; Deborah K Hoshizaki; Laurence von Kalm; Charles A Fuller; Kathleen M Beckingham; Deborah A Kimbrell
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.